Dr. Linda Terry, a highly recognized scientific leader, has joined Immunologix from her role as Group Lead, Exploratory Biomarkers, at GSK where she led a team of scientists developing and validating biomarker assays in support of early-stage programs from candidate selection to first in human trials. Dr. Terry graduated from University College London in the UK with a doctorate in immunology and her diverse career has traversed academia, government research and the pharmaceutical industry, enabling her to build strong foundational knowledge across multiple disease areas. She brings over two decades of experience in the development and implementation of biomarker strategies and associated assays with particular interest in building translational strategies that effectively drive early phases of drug development, from lead optimization through to proof of concept. Dr. Terry%u2019s scientific network spans two continents, where she is a highly sought-after speaker and panelist at international conferences and has served as a core committee member of the Biomarker Focus Workshops for the European Bioanalytical Forum in 2019 and 2020. An analytical problem solver with a passion for building highly collaborative teams focused on finding effective and efficient solutions that facilitate patient-focused drug development, Dr. Terry is also an impassioned people developer and coach, who firmly believes that an empowered and engaged employee community drives excellence and innovation.